T-cell Redirecting Therapy for Multiple Myeloma
Dr. Martha Louzada breaks down T-cell redirecting therapy for multiple myeloma — what it actually is, how it fits into the broader treatment landscape, and what patients and caregivers should know from this year's ASH conference highlights.
_________
Founded in 2005, Myeloma Canada is the only national patient-focused charitable organization dedicated to addressing the holistic needs of people impacted by multiple myeloma. Guided by its vision of a life uninterrupted by myeloma, it works to improve lives, increase access to optimal care, and advance research toward a cure.
For more information, visit: https://www.myeloma.ca
#MultipleMyeloma #CarTcellTherapy #MyelomaTreatment #CancerTreatment